IRST - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Arog Pharmaceuticals, Inc.1 trial
• International Extranodal Lymphoma Study Group (IELSG)1 trial

Closed trials

• Completed

  Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

  NCT03250338· Phase 3· Arog Pharmaceuticals, Inc.· Source

• Completed

  New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

  NCT02329080· Phase 2· International Extranodal Lymphoma Study Group (IELSG)· Source